Skip to content
Quickspace Central

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Deal Because of Information Concerns

Health aid image
The proposed American funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's insistence on confidential biological samples.

The decision came to light after a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".

An official representative has since explained that the United States was demanding access to biological samples for research and commercial gain while refused to guarantee the resulting advantages from any future medical innovations.

"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged more negotiations to reach a deal acceptable to both sides so the country's vital HIV programme can proceed.

Wider Background

This rejection comes after a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.

After returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.

According to reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn in new funding.

Specifics of the Rejected Agreement

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"Effectively, our country would provide the raw materials for medical research with no certainty that the resulting innovations would be accessible to our population should a future disease outbreak arise."

Sovereignty and Global Health

Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting structures already set up via the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage future pandemics.

"This framework is designed to ensure that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."

The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome ongoing discussions with our US partners on how future collaboration could be designed in a way that respects the independence and interests of each country."

Health Experts Response

Medical experts said it understood the official position, but urged that talks must proceed since much of the nation's HIV programmes relied on international support.

"If specific concerns exist, such as those relating to data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," it commented.

The situation highlights the complex challenges between accepting crucial international aid and protecting a country's data in an increasingly data-driven world.

JS
By

James Sanders

Lena is een ervaren ondernemer en interieurontwerper met een passie voor slimme werkruimtes.

Quickspace Central

Type to search articles.